To conclude, the overall presented data suggest that IRE1/XBP1s signaling may in some conditions act as a tumor suppressor pathway in AML, in particular through activation of the XBP1s/miR-22/SIRT1 axis. The gene discussed is SIRT1; the disease is acute myeloid leukemia.